Article info

Download PDFPDF

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis

Authors

  1. Correspondence to Dr Margaret Gatti-Mays; margaret.gatti-mays{at}osumc.edu

Citation

Gatti-Mays M, Gulley JL
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis

Publication history

  • Accepted January 12, 2021
  • First published February 18, 2021.
Online issue publication 
February 18, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.